EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Different actions of deferoxamine and iron on gallium 67 abscess detection in rats


, : Different actions of deferoxamine and iron on gallium 67 abscess detection in rats. Journal of Nuclear Medicine 25(6): 668-672

The contrast-enhancing properties of Fe and deferoxamine (DFO) in abscess imaging with 67Ga citrate were compared in rats bearing turpentine-induced abscesses. Iron administration shifted 67Ga from plasma into tissues such as muscle and fat. As a result, the abscess-to-plasma ratio increased whereas the abscess-to-muscle ratio decreased. DFO enhanced the abscess-to-muscle and abscess-to-plasma ratios by increasing urinary 67Ga excretion. In contrast to Fe, DFO removed abscess-bound 67Ga, thus representing a disadvantage of DFO compared with Fe. As a result, the abscess-to-plasma ratio was more effecively enhanced by Fe than by DFO. Abscess imaging with 67Ga citrate may be improved by administration of Fe for detection of abscesses masked by blood activity, or DFO for detection of abscesses surrounded by muscle tissue.


Accession: 005151830

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Oberhaensli, R.D.; Mueller, R.M.; Fridrich, R., 1984: Different actions of deferoxamine and iron on Ga-67 abscess detection in rats. The contrast-enhancing properties of iron (Fe) and deferoxamine (DFO) in abscess imaging with Ga-67 citrate were compared in rats bearing turpentine-induced abscesses. Iron administration shifted Ga-67 from plasma into tissues such as muscle and f...

Yokoyama A.; Ohmomo Y.; Horiuchi K.; Saji H.; Tanaka H.; Yamamoto K.; Ishii Y.; Torizuka K., 1982: Deferoxamine a promising bi functional chelating agent for labeling proteins with gallium gallium 67 labeled deferoxamine human serum albumin concise communication. A new efficient method was developed for the labeling of various biologically important proteins with radiogallium, using deferoxamine (DF) as a bifunctional chelating agent. Human serum albumin (HSA) was chosen for studying the DF coupling reacti...

Oster Z.H.; Som P.; Sacker D.F.; Atkins H.L., 1980: Effects of deferoxamine mesylate on gallium 67 distribution in normal and abscess bearing animals. Deferoxamine mesylate (DFO), given to rabbits 20 min after gallium-67 citrate, induces prompt and rapid urinary excretion of Ga-67 activity with concommitant decrease in blood and muscle activity with concommitant decrease in blood and muscle acti...

Mazaheri, S.; Moaeidi, B.Alsaadat.; Nematbakhsh, M., 2014: Re: "Protective Role of Silymarin and Deferoxamine against Iron Dextran-Induced Renal Iron Deposition in Male Rats," and "Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model". International Journal of Preventive Medicine 5(6): 800-801

Oster, Z.H.; Som, P.; Sacker, D.F.; Atkins, H.L., 1980: The effects of deferoxamine mesylate on gallium-67 distribution in normal and abscess-bearing animals: concise communication. Deferoxamine mesylate (DFO), given to rabbits 20 min after gallium-67 citrate, induces prompt and rapid urinary excretion of Ga-67 activity with concommitant decrease in blood and muscle activity. When DFO is given after 2 hr or later, the effect...

Gale, G.R.; Litchenberg, W.H.; Smith, A.B.; Singh, P.K.; Campbell, R.A.; Jones, M.M., 1991: Comparative iron mobilizing actions of deferoxamine, 1,2-dimethyl-3-hydroxypyrid-4-one, and pyridoxal isonicotinoyl hydrazone in iron hydroxamate-loaded mice. A comparison was made of the actions of deferoxamine (DFX), 1,2-dimethyl-3-hydroxypyrid-4-one (L1), and pyridoxal isonicotinoyl hydrazone (PINH) in mobilizing and promoting excretion of iron in mice loaded with iron-acetohydroxamic acid complex. D...

Caraco, C.; Aloj, L.; Eckelman, W.C., 1998: The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions. Previous studies report that deferoxamine (DFO) binds metallic ions such as Fe3+, In3+ and Ga3+ with very high affinity. This property of DFO has been utilized to label DFO-coupled compounds with radiometals such as 67Ga and 111In. We have studied...

Baker, D.L.; Manno, C.S., 1988: Rapid excretion of gallium-67 isotope in an iron-overloaded patient receiving high-dose intravenous deferoxamine. A 23 year-old black male with homozygous sickle cell disease (Hb SS disease) and transfusional iron overload was admitted for evaluation of response to intravenous deferoxamine (DFO) therapy. Soon after admission, the patient suffered an intravent...

Yokoyama A.; Omomo Y.; Horiuchi K.; Saji H.; Yamamoto K.; Ishii Y.; Tanaka H.; Torizuka K., 1981: Deferoxamine an excellent bi functional chelating agent for labeling proteins with gallium gallium 67 labeled human serum albumin. Journal of Nuclear Medicine 22(6): P32-P33

Link, G.; Konijn, A.M.; Breuer, W.; Cabantchik, Z.I.; Hershko, C., 2001: Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture. Although iron chelation therapy results in a significant improvement in well-being and life expectancy of thalassemic patients with transfusional iron overload, failure to achieve these goals in a substantial proportion of patients underlines the...